Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients …
MM Fernandez, J Wang, X Ye, WJ Kwong… - SAGE Open …, 2015 - journals.sagepub.com
Background: The nonvitamin K antagonist oral anticoagulants pivotal clinical trials for stroke
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients …
MM Fernandez, J Wang, X Ye… - SAGE open …, 2015 - pubmed.ncbi.nlm.nih.gov
Background The nonvitamin K antagonist oral anticoagulants pivotal clinical trials for stroke
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
[PDF][PDF] Winghan Jacqueline Kwong2, Bintu Sherif1, Susan Hogue1 and Beth Sherrill1
MM Fernandez, J Wang, X Ye - 2015 - rtihs.org
Background: The nonvitamin K antagonist oral anticoagulants pivotal clinical trials for stroke
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients …
MM Fernandez, J Wang, X Ye, WJ Kwong… - SAGE Open …, 2015 - europepmc.org
Background The nonvitamin K antagonist oral anticoagulants pivotal clinical trials for stroke
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
[HTML][HTML] Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among …
MM Fernandez, J Wang, X Ye, WJ Kwong… - SAGE Open …, 2015 - ncbi.nlm.nih.gov
Background: The nonvitamin K antagonist oral anticoagulants pivotal clinical trials for stroke
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
[PDF][PDF] Winghan Jacqueline Kwong2, Bintu Sherif1, Susan Hogue1 and Beth Sherrill1
MM Fernandez, J Wang, X Ye - 2015 - cyberleninka.org
Background: The nonvitamin K antagonist oral anticoagulants pivotal clinical trials for stroke
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients …
MM Fernandez, J Wang, X Ye, WJ Kwong… - SAGE Open …, 2015 - search.ebscohost.com
Background: The nonvitamin K antagonist oral anticoagulants pivotal clinical trials for stroke
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients …
MM Fernandez, J Wang, X Ye, WJ Kwong… - SAGE Open …, 2015 - europepmc.org
Background The nonvitamin K antagonist oral anticoagulants pivotal clinical trials for stroke
prevention in atrial fibrillation have important differences in trial designs and baseline patient …
prevention in atrial fibrillation have important differences in trial designs and baseline patient …